June 19, 2017 Lab Top-10 M&A, Partnerships

PerkinElmer to Acquire EUROIMMUN for Approximately $1.3 Billion

Accelerates revenue and earnings growth by adding leading positions in autoimmune and allergy diagnostics and strengthens leadership in China and other emerging markets Significant opportunity to leverage technologies, strong market positions and synergistic commercial activities to deliver better solutions across an expanding customer base Highly compelling deployment of capital, significantly advancing PerkinElmer’s strategic priorities and... Read more

May 1, 2017 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

PerkinElmer Completes Sale of Medical Imaging Business to Varex Imaging

WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the company has completed the sale of its Medical Imaging business to Varex Imaging Corporation (Nasdaq: VREX). PerkinElmer announced its intent to sell its Medical Imaging business, a supplier of flat panel X-ray detectors that... Read more

April 7, 2017 Lab Top-10 PR/Corporate

PerkinElmer to Hold Earnings Call on Thursday, May 4, 2017

WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc., (NYSE:PKI) a global leader committed to innovating for a healthier world, today announced that on Thursday, May 4, 2017, after market close, the Company will release first quarter 2017 results. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss these results. Robert... Read more

April 5, 2017 Bio/Pharma/CRO Clinical Research/Diagn. Lab Top-10

Phase I Clinical Trial Examines Safety of Using Cord Blood Stem Cells for Treating Children with Autism Spectrum Disorder

Preliminary Findings Indicate Potential Efficacy of Cord Blood to Improve the Lives of Children with Social and Behavioral Challenges Associated with ASD WALTHAM, Mass. –  April 5, 2017–  Novel research results from Duke University’s Robertson Clinical and Translational Cell Therapy Program published today in the April issue of Stem Cells Translational Medicine indicate promising developments... Read more